Anticoagulation management in patients undergoing open heart surgery by activated clotting time and whole blood heparin concentration

Perfusion

Volumn 21, Issue 5, 2006, Pages 285-290

  Pappalardo, Federico ^a   Franco, Annalisa ^a   Crescenzi, Giuseppe ^a   de Simone, Francesco ^a   Torracca, Lucia ^a   Zangrillo, Alberto ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; HEPARIN; PROTAMINE; TRANEXAMIC ACID; ANTICOAGULANT AGENT; HEPARIN ANTAGONIST;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING TIME; BLOOD TRANSFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG MEGADOSE; ELECTIVE SURGERY; FEMALE; HEART DISEASE; HEMOSTASIS; HUMAN; LOW DRUG DOSE; MALE; OPEN HEART SURGERY; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE COUNT; TREATMENT RESPONSE; AGED; BLOOD; CARDIOPULMONARY BYPASS; COMPARATIVE STUDY; HEART VALVE; HEART VALVE REPLACEMENT; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; STATISTICS; THROMBOSIS; TREATMENT OUTCOME;

ADULT; AGED; ANTICOAGULANTS; CARDIOPULMONARY BYPASS; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HEART VALVES; HEPARIN; HEPARIN ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROTAMINES; THROMBOSIS; TREATMENT OUTCOME; WHOLE BLOOD COAGULATION TIME;

EID: 33947244631     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/0267659106074770     Document Type: Article

References (17)

1. Gravlee GP, Case LD, Angert KC, Rogers AT, Millerb GS. Variability of the activated coagulation time. Anesth Analg 1988; 67: 469-72.
2. Cohen EJ, Cameriengo LJ, Dearing JP. Activated clotting times and cardiopulmonary bypass: the effect of hemodilution and hypothermia upon activated clotting time. J Extracorp Tech 1980; 12: 139-41.
3. Casati V, Della Valle P, Benussi S et al. Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: comparison between on-pump and off-pump techniques. J Thorac Cardiovasc Surg 2004; 128: 83-91.
4. Buckberg GD, Beyersdorf F, Allen BS, Robertson JM. Integrated myocardial management: background and initial application. J Card Surg 1995; 10: 68-89.
5. Jobes DR, Schwartz AJ, Ellison N, Andrews R, Ruffini RA, Ruffini JJ. Monitoring heparin anticoagulation and its neutralization. Ann Thorac Surg 1980; 31: 161-66.
6. Boldt J, Schindler E, Osmer C, Wittstock M, Stertmann WA, Hempelmann G. Influence of different anticoagulation regimens on platelet function during cardiac surgery. Br J Anesth 1994; 73: 639-44.
7. Moorehead MT, Westengard JC, Bull BS. Platelet involvement in the activated coagulation time of heparinized blood. Anesth Analg 1984; 63: 394-98.
8. Wahr JA, Yun JH, Yang VC, Lee LM, Fu B, Meyerhoff ME. A new method of measuring heparin levels in whole blood by protamine titration using a heparin-responsive electrochemical sensor. J Cardiothorac Vasc Anesth 1996; 10: 447-50.
9. Despotis GJ, Joist JH, Goodnough LT, Santoro SA, Spitznagel E. Whole blood heparin concentration measurement by automated protamine titration agree with plasma anti-Xa measurements. J Thorac Cardiovasc Surg 1996; 170: 611-13.
10. Koster A, Fisher T, Praus M et al. Hemostatic activation and inflammatory response during cardiopulmonary bypass. Impact of heparin management. Anesthesiology 2002; 97: 837-41.
11. Stafford-Smith M, Lefrak EA, Qazi AG et al. Efficacy and safety of heparinase I versus protamine in patients undergoing coronary artery bypass grafting with and without cardiopulmonary bypass. Anesthesiology 2005; 103: 229-40.
12. Ammar T, Fisher TF. The effects of heparinase1 and protamine on platelet reactivity. Anesthesiology 1997; 86: 1382-86.
13. DeLaria GA, Tyner JJ, Hayes CL, Armstrong BW. Heparin-protamine mismatch: a controllable factor in bleeding after open heart surgery. Arch Surg 1994; 129: 944-50.
14. Jobes DR, Aitken GL, Shaffer GW. Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations. J Thorac Cardiovasc Surg 1995; 110: 36-45.
15. Shigeta O, Kojima H, Hiramatsu Y et al. Low dose protamine based on heparin-protamine titration method reduces platelet dysfunction after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1999; 118: 354-60.
16. Welsby IJ, Newman MF, Philips-Bute B, Messier RH, Kakkis ED, Stafford-Smith M. Hemodynamic changes after protamine administration: association with mortality after coronary artery bypass surgery. Anesthesiology 2005; 102: 308-14.
17. Despotis GJ, Joist JH, Hogue CW Jr et al. The impact of heparin concentration and activated clotting time monitoring on blood conservation: a prospective, randomised evaluation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg 1995; 110: 46-54.